Exercise Mode and Bone
Primary Purpose
Osteoporosis, Aging
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise Mode
Sponsored by
About this trial
This is an interventional prevention trial for Osteoporosis focused on measuring exercise, bone resorption, calcium
Eligibility Criteria
Inclusion Criteria:
- Healthy older (60+ y) Veteran women and men will be eligible to participate
- All volunteers must be accustomed to performing 60 minutes of vigorous cycling and treadmill exercise
Exclusion Criteria:
- impaired renal function, defined as an eGRF of <60 mL/min/1.73m2;(Florkowski and Chew-Harris 2011)
- hepatobiliary disease, defined as liver function tests (AST, ALT) >1.5 times the upper limit of normal
- thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH) <0.5 or >5.0 mU/L
- serum Ca <8.5 or >10.3 mg/dL; 5) serum 25(OH)D <20 ng/mL
- uncontrolled hypertension, defined as resting systolic blood pressure (BP) >150 mmHg or diastolic BP >90 mmHg
- history of type 1 or type 2 diabetes
cardiovascular disease; defined as subjective or objective indicators of ischemic heart disease (e.g., angina, ST segment depression) or serious arrhythmias at rest or during the graded exercise test (GXT)
- volunteers who have a positive GXT can be re-considered after follow-up evaluation, which must include diagnostic testing (e.g., stress echocardiogram or thallium stress test) with interpretation by a cardiologist
- anemia, defined as a serum hemoglobin <12.1 g/dL for women and <14.3 g/dL for men
- fracture in the past 6 months
current diagnosis or symptoms of COVID-19
- In the event of abnormal BP, live function, TSH, 25(OH)D, or hemoglobin values, volunteers can be reassessed, including after appropriate follow-up evaluation and treatment by a primary care provider
- Those who have experienced symptoms of COVID-19 or have been formally diagnosed will be allowed to participate once symptoms have resolved and they are approved to return to exercise by their primary care provider
Sites / Locations
- Rocky Mountain Regional VA Medical Center, Aurora, CORecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Stationary Cycling
Treadmill Walking
Arm Description
All participants will complete one, 60-minute bout of stationary cycling
All participants will complete one, 60-minute bout of treadmill walking
Outcomes
Primary Outcome Measures
c-telopeptide of type I collagen (CTX) change
CTX is a blood marker of bone resorption. Reference range is 0.1-0.8 ng/mL with lower concentrations suggesting less bone resorption.
Secondary Outcome Measures
procollagen of type I n-terminal propeptide (P1NP) change
PINP is a blood marker of bone formation. Reference range is 19-80 ng/mL with lower concentrations suggesting less bone formation.
Full Information
NCT ID
NCT04815824
First Posted
March 22, 2021
Last Updated
June 8, 2023
Sponsor
VA Office of Research and Development
Collaborators
University of Colorado, Denver
1. Study Identification
Unique Protocol Identification Number
NCT04815824
Brief Title
Exercise Mode and Bone
Official Title
Comparison of Exercise Mode on Disruptions in Calcium Homeostasis
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 8, 2021 (Actual)
Primary Completion Date
June 3, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development
Collaborators
University of Colorado, Denver
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Endurance exercise is often recommended to improve cardiometabolic health and maintain bone health throughout life and to prevent osteoporotic fracture. However, there is evidence to suggest that bone does not always adapt in the way that is expected, and that endurance exercise may lead to bone loss under certain conditions. Disruptions in calcium homeostasis during exercise may explain this observation, and preliminary data suggests that the mode of exercise (i.e., cycling versus treadmill) may result in different magnitudes of change in bone biomarkers. The purpose of this study is to determine if mode of exercise results in a differential bone biomarker response to an acute exercise bout in older Veterans. Blood samples will be collected before, during, and after 2 acute exercise bouts: 1) brisk treadmill walking; and 2) vigorous stationary cycling. Bouts will be matched for relative intensity and duration. This data will be used to develop future exercise interventions in older Veterans aimed at preserving both cardiometabolic and bone health.
Detailed Description
Endurance exercise is frequently recommended as a means to reduce the risk of cardiometabolic diseases and to reduce the risk of osteoporotic fracture. However, bone does not always adapt in the way that would be expected, and there is evidence that endurance exercise may lead to bone loss under certain conditions. It is the investigators contention that disruptions in calcium homeostasis during exercise, resulting in decreases in serum ionized calcium (iCa) and increases in parathyroid hormone (PTH) and c-telopeptide of type I collagen (CTX; a marker of bone resorption) at the onset of exercise, may be responsible for the lack of improvements in bone mineral density that are anticipated. Acute studies in this area have predominantly focused on young, healthy adults, primarily men, during stationary cycling exercise. Few studies have been conducted in older adults, but those studies have found that older adults experience similar disruptions in calcium homeostasis in response to an acute bout of endurance exercise. Preliminary comparisons of the investigators studies, as well as research from other labs, also suggests that that mode of exercise conducted during these acute exercise bouts may be an important determining factor in the catabolic bone response to exercise. It appears that weight-bearing exercise (i.e., treadmill) results in smaller increases in PTH and CTX compared to weight-supported exercise (i.e., stationary cycling). This has never been tested using a within-subjects design, so it is unclear if these observed differences are due to the mode of exercise, lab-to-lab differences, or other underlying factors. To address this gap in knowledge, 30 Veterans (15 men, 15 women), aged 60+ years, will complete two 1-hour acute exercise bouts: 1) brisk treadmill walking at 70-80% of maximal heart rate; 2) vigorous stationary cycling at 70-80% maximal heart rate. Blood samples will be collected to measure iCa, PTH, CTX and procollagen type I n-terminal propeptide (P1NP) before, during, and after each exercise bout. The order of the exercise bouts will be randomized and counter-balanced. The primary aim is to determine if mode of exercise results in a differential bone biomarker response in older Veterans. This information is essential for understanding how future exercise interventions should be designed to benefit both cardiometabolic health and bone health. This is especially relevant to Veteran health due to the high burden of both cardiometabolic diseases (e.g., diabetes, heart disease) in the population, as well as evidence of increased osteoporotic fracture risk. The proposed research is significant because it is addressing a knowledge gap that has prevented the ability to design exercise and lifestyle interventions aimed at preserving multiple components of Veteran health, which could have a lasting impact on Veteran quality of life and functional independence. The proposed research is innovative because it is testing a novel hypothesis, the mode of exercise on disruptions in calcium homeostasis, in a population that could greatly benefit from the knowledge to be gained. While the proposed research is an acute study, the results generated will be used to design future clinical interventions for Veteran health. Long-term, information gained from this research will help to define the optimal exercise prescription to improve cardiometabolic without compromising bone health aging Veterans.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoporosis, Aging
Keywords
exercise, bone resorption, calcium
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Crossover design comparing mode of endurance exercise (cycling versus treadmill).
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Stationary Cycling
Arm Type
Experimental
Arm Description
All participants will complete one, 60-minute bout of stationary cycling
Arm Title
Treadmill Walking
Arm Type
Experimental
Arm Description
All participants will complete one, 60-minute bout of treadmill walking
Intervention Type
Behavioral
Intervention Name(s)
Exercise Mode
Intervention Description
Stationary cycling or treadmill walking
Primary Outcome Measure Information:
Title
c-telopeptide of type I collagen (CTX) change
Description
CTX is a blood marker of bone resorption. Reference range is 0.1-0.8 ng/mL with lower concentrations suggesting less bone resorption.
Time Frame
Before to up to 48 hours after acute exercise bout
Secondary Outcome Measure Information:
Title
procollagen of type I n-terminal propeptide (P1NP) change
Description
PINP is a blood marker of bone formation. Reference range is 19-80 ng/mL with lower concentrations suggesting less bone formation.
Time Frame
Before to up to 48 hours after acute exercise bout
10. Eligibility
Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy older (60+ y) Veteran women and men will be eligible to participate
All volunteers must be accustomed to performing 60 minutes of vigorous cycling and treadmill exercise
Exclusion Criteria:
impaired renal function, defined as an eGRF of <60 mL/min/1.73m2;(Florkowski and Chew-Harris 2011)
hepatobiliary disease, defined as liver function tests (AST, ALT) >1.5 times the upper limit of normal
thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH) <0.5 or >5.0 mU/L
serum Ca <8.5 or >10.3 mg/dL; 5) serum 25(OH)D <20 ng/mL
uncontrolled hypertension, defined as resting systolic blood pressure (BP) >150 mmHg or diastolic BP >90 mmHg
history of type 1 or type 2 diabetes
cardiovascular disease; defined as subjective or objective indicators of ischemic heart disease (e.g., angina, ST segment depression) or serious arrhythmias at rest or during the graded exercise test (GXT)
volunteers who have a positive GXT can be re-considered after follow-up evaluation, which must include diagnostic testing (e.g., stress echocardiogram or thallium stress test) with interpretation by a cardiologist
anemia, defined as a serum hemoglobin <12.1 g/dL for women and <14.3 g/dL for men
fracture in the past 6 months
current diagnosis or symptoms of COVID-19
In the event of abnormal BP, live function, TSH, 25(OH)D, or hemoglobin values, volunteers can be reassessed, including after appropriate follow-up evaluation and treatment by a primary care provider
Those who have experienced symptoms of COVID-19 or have been formally diagnosed will be allowed to participate once symptoms have resolved and they are approved to return to exercise by their primary care provider
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sarah J Wherry, PhD
Phone
(720) 848-6475
Email
sarah.wherry@va.gov
First Name & Middle Initial & Last Name or Official Title & Degree
Toby Wellington, MS
Phone
(720) 848-6376
Email
toby.wellington@va.gov
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sarah J Wherry, PhD
Organizational Affiliation
Rocky Mountain Regional VA Medical Center, Aurora, CO
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rocky Mountain Regional VA Medical Center, Aurora, CO
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sarah J Wherry, PhD
Phone
720-848-6475
Email
sarah.wherry@va.gov
First Name & Middle Initial & Last Name & Degree
Sarah J Wherry, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Exercise Mode and Bone
We'll reach out to this number within 24 hrs